[B! è«–æ–‡] anpakuã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

anpaku id:anpaku

è«–æ–‡ã«é–¢ã™ã‚‹anpakuã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (21)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

ç”Ÿæˆç³»AI(ChatGPT, BingAI, Bard, Midjourney, Stable Diffusionç‰)ã«ã¤ã„ã¦
å„ç¨®æ–¹é‡ç‰ arrow_forward_iosç”Ÿæˆç³»AIã«ã¤ã„ã¦ ç”Ÿæˆç³»AI(ChatGPT, BingAI, Bard, Midjourney, Stable Diffusionç‰)ã«ã¤ã„ã¦ 2023å¹´4æœˆ3æ—¥ æ±äº¬å¤§å¦ç†äº‹ãƒ»å‰¯å¦é•·ï¼ˆæ•™è‚²ãƒ»æƒ…å ±æ‹…å½“ï¼‰ å¤ªç”°ã€€é‚¦å² ã“ã®åŠå¹´ã»ã©ã®æœŸé–“ã§ã€ç”Ÿæˆç³»äººå·¥çŸ¥èƒ½(Generative AI)ãŒè¤‡æ•°ç™ºè¡¨ã•ã‚Œã€ç¤¾ä¼šçš„ã«å¤§ããªæ³¨ç›®ã‚’é›†ã‚ã¦ã„ã¾ã™ã€‚åŸºæœ¬çš„ã«ã¯ã€ã‚¤ãƒ³ã‚¿ãƒ¼ãƒãƒƒãƒˆä¸Šãªã©ã«å˜åœ¨ã™ã‚‹æ—¢å˜ã®æ–‡ç« ã‚„ç”»åƒã‚¤ãƒ¡ãƒ¼ã‚¸ã‚’å¤§é‡ã«æ©Ÿæ¢°å¦ç¿’ã—ã€ã“ã‚Œã«å¼·åŒ–å¦ç¿’ã‚’çµ„ã¿åˆã‚ã›ãªã©ã—ã¦ã€ä¸€å®šãƒ¬ãƒ™ãƒ«ã®å“è³ªã®æ–‡ç« ã‚„ç”»åƒã‚’ç”Ÿæˆã™ã‚‹ã‚·ã‚¹ãƒ†ãƒ ã§ã™ã€‚ã¨ãã«ã€2022å¹´11æœˆã«å…¬é–‹ã•ã‚Œã€è©±é¡Œã«ãªã£ãŸå¤§è¦æ¨¡è¨€èªžãƒ¢ãƒ‡ãƒ«ChatGPTã¯ãƒãƒ¼ã‚¸ãƒ§ãƒ³ãŒæ›´æ–°ã•ã‚Œã€æœ€æ–°ã®GPT-4ã§ã¯ç”Ÿæˆã•ã‚Œã‚‹æ–‡ç« ãªã©ã®è³ªã‚„æ£ç¢ºæ€§ãŒè‘—ã—ãå‘ä¸Šã—ã¦ã„ã¾ã™1ã€‚ ã“ã‚Œã‚‰ã®ç”Ÿæˆç³»AIã¯ã€å¹³å’Œçš„ã‹ã¤ä¸Šæ‰‹ã«åˆ¶å¾¡ã—ã¦åˆ©ç”¨ã™ã‚Œã°ã€äººé¡žã®
anpaku 2023/04/03
ç”»åƒç”Ÿæˆç³»AIã¯ã€ä»Šå¾Œã©ã®æ–¹å‘ã«å‘ã‹ã£ã¦ã„ãã®ã ã‚ã†ã‹ã€‚

AI

å¦ç¿’

è«–æ–‡
ãƒªãƒ³ã‚¯
ChatGPTãŒæ–°ç€è«–æ–‡ã‚’è¦ç´„ã—æ¯Žæœãƒ¡ãƒ¼ãƒ«ã—ã¦ãã‚Œã‚‹ä»•çµ„ã¿ã®ä½œã‚Šæ–¹ | Antaa Slide
2024å¹´9æœˆ18æ—¥è¿½è¨˜ gpt-3.5-turboã®ã‚µãƒ¼ãƒ“ã‚¹çµ‚äº†ã«ä¼´ã„ã€gpt-4o-miniã«å¤‰æ›´ã™ã‚‹æ–¹æ³•ã®ã‚¹ãƒ©ã‚¤ãƒ‰ã‚’è¿½åŠ ã€‚ 2024å¹´3æœˆ13æ—¥è¿½è¨˜ ãƒ»OpneAIã®APIèª²é‡‘ã‚·ã‚¹ãƒ†ãƒ å¤‰æ›´ã«ä¼´ã†ã‚¨ãƒ©ãƒ¼ã«ã¤ã„ã¦è§£èª¬ã€‚ 10æœˆ26æ—¥è¿½è¨˜ ãƒ»ãƒ¡ãƒ¼ãƒ«ãŒå±Šã‹ãªããªã£ãŸéš›ã«æ¨©é™ã®å†æ‰¿èªãŒå¿…è¦ãªä»¶ã€‚ 5æœˆ11æ—¥è¿½è¨˜ ãƒ»æ¤œç´¢ã«ã‹ã‹ã£ãŸè«–æ–‡ã«æŠ„éŒ²ãŒãªã„å ´åˆã€AIãŒè¦ç´„ã‚’å‰µé€ (æé€ )ã™ã‚‹ä»¶ã€‚ 4æœˆ21æ—¥è¿½è¨˜ ãƒ»ä½œã‚Šæ–¹ã®ã‚µã‚¤ãƒˆã§ã¯ãªãå…¬é–‹ã•ã‚ŒãŸLINE Botã®ãƒªãƒ³ã‚¯ã«åˆ‡ã‚Šæ›¿ãˆã€‚ ãƒ»ã‚¨ãƒ©âˆ’429ãŒå‡ºãŸå ´åˆ4ã®ã‚¹ãƒ©ã‚¤ãƒ‰ã‚’è¿½åŠ ã€‚ 4æœˆ10æ—¥è¿½è¨˜ ãƒ»é€ä¿¡ãƒˆãƒªã‚¬ãƒ¼ã®å¤‰æ›´æ–¹æ³•ã®ã‚¹ãƒ©ã‚¤ãƒ‰ã‚’è¿½åŠ ã€‚ ãƒ»è¤‡æ•°ã‚ãƒ¼ãƒ¯ãƒ¼ãƒ‰ã‚„é›‘èªŒã‚’æŒ‡å®šã—ã¦æ¤œç´¢ã™ã‚‹æ–¹æ³•ã®ã‚¹ãƒ©ã‚¤ãƒ‰ã‚’è¿½åŠ ã€‚ ãƒ‡ãƒ¢ã‚³ãƒ¼ãƒ‰ã¯ã€ const PUBMED_QUERY = '(aaa) AND (bbb) AND (("ccc"[Journal]) OR ("ddd"[Jo
anpaku 2023/03/26
ã“ã‚Œã¯å¿…è¦‹ã§ã™ããƒ¼ã€‚å‹‰å¼·ã—ã¾ã™ã€‚ã‚ã‚ŠãŒã¨ã†ã”ã–ã„ã¾ã™â™ª

è«–æ–‡

ãƒ—ãƒã‚°ãƒ©ãƒŸãƒ³ã‚°

AI
ãƒªãƒ³ã‚¯
åƒ•ã¯è«–æ–‡ãŒæ›¸ã‘ãªã„ - Life is Beautiful
ã“ã®è¨˜äº‹ã¯ã€æ•°ç†ç”Ÿç‰©å¦ä¼šãƒ‹ãƒ¥ãƒ¼ã‚¹ãƒ¬ã‚¿ãƒ¼ï¼ˆ2021å¹´10æœˆï¼‰ã«æŽ²è¼‰ã•ã‚ŒãŸå†…å®¹ã‚’ã€ã„ãã¤ã‹ã®ã‚¿ã‚¤ãƒã‚’ä¿®æ£ã—ãŸä¸Šã§ã€æŽ²è¼‰ã—ãŸã‚‚ã®ã§ã™ã€‚ â– åºè¨€ å…‰æ „ãªã“ã¨ã«ã€æ—¥æœ¬æ•°ç†ç”Ÿç‰©å¦ä¼šã‹ã‚‰ã€ã€Œç ”ç©¶å¥¨åŠ±è³žã€ã‚’æŽˆã‹ã£ãŸã€‚ãã®å¥¨åŠ±è³žã«å¯„ã›ã‚‹æœ¬ç¨¿ã¯ã€ç ”ç©¶å†…å®¹ã‚’æ•´ç†ã—ãŸã‚Šå°†æ¥ã®å±•æœ›ã‚’èª¬ãã€è‰¯ã„æ©Ÿä¼šã¨æ€ãˆã‚‹ã€‚ã—ã‹ã—ãã‚Œã¯ã—ãªã„ã€‚ã‹ã‚ã‚Šã«ã€è³žã«ç„¡ç¸ã§è‡ªä¿¡å–ªå¤±çš„ã§è«–æ–‡ã‚’ãƒ†ãƒ³ãƒã‚ˆãå‡ºç‰ˆã§ãã¬ã€çœŸé¢ç›®ã ãŒã„ã‹ã«ç„¡ç²¾è€…ã ã£ãŸã‹ã‚’ã€æ„å‘³ã‚ã‚‹å½¢ã§ã€ãŠã‚‚ã«ç§ã‚ˆã‚Šè‹¥ã„ã‚¹ãƒ†ãƒ¼ã‚¸ã®æ–¹ã¸å‘ã‘ã¦ã€è¿°ã¹ãŸã„ã€‚æœ¬ç¨¿ãŒå°‘ã—ã§ã‚‚åŠ±ã¿ã«ãªã‚‹ã¨å¬‰ã—ã„ã€‚ ä»¥ä¸‹ã€ç§ã¯ã€ŒçœŸé¢ç›®ç³»ã€ã¨ã„ã†è¨€è‘‰ã‚’é »ç”¨ã™ã‚‹ãŒã€ãã‚Œã¯ã‚ãã¾ã§ç§è‡ªèº«ã®ã¿ã‚’æŒ‡ã™æ‰¹åˆ¤çš„ãªè¡¨ç¾ã¨ã™ã‚‹ã€‚ã¾ãŸã€ä»¥ä¸‹ã«ã¯å°‘ã—ã ã‘ã®è¦‹æ „ãƒ»è‡ªæ…¢ã‚‚å«ã¾ã‚Œã‚‹ã€‚ã ãŒç§ãŒå¤§å¦é™¢ç”Ÿã®é–“ã«è‡ªæ…¢ã§ãã‚‹ã“ã¨ã¯ã»ã¨ã‚“ã©ãªã„ã€‚ â– çœŸé¢ç›®ç³»ç„¡ç²¾è€…ã®èª•ç”Ÿã¨ã€è‡ªç«‹ã—ãŸç ”ç©¶è€…ã¸ã®æŽ¨ç§» è»¢æ©Ÿ1ï¼šç ”ç©¶ã‚ˆã‚Šå‹‰å¼· ç§ã®ç ”ç©¶æ´»å‹•ã¯M1/2011å¹´4æœˆã€ä¹
anpaku 2021/10/24
å¾Œã§èªã¿ãŸã„ã¨æ€ã„ã¾ã™ã€‚

å¦ä¼š

è«–æ–‡

ç ”ç©¶
ãƒªãƒ³ã‚¯
https://www.osaka-u.ac.jp/ja/news/info/corona/corona_info/from_members/rcnp_nakano
anpaku 2020/11/26
ç†è«–æ¦è£…ã§ã™ãã€‚Kå€¤ã§ã€‚

è«–æ–‡
ãƒªãƒ³ã‚¯
å†…ç§‘åŒ»ã®ãƒŽãƒ¼ãƒˆ (Diabetologistnote)
1åž‹ç³–å°¿ç—…ï¼ˆ8æ³ã‹ã‚‰17æ³ã€C-peptide 0.2 pmol/ml ä»¥ä¸Šï¼‰ã§ã€Teplizumabã€€ï¼’ã‚¯ãƒ¼ãƒ«ã®æŠ•ä¸Žã¯Î²ç´°èƒžæ©Ÿèƒ½ã‚’ä¿è·ã™ã‚‹ã€‚ 8æ³ã‹ã‚‰17æ³ã€è¨ºæ–ã‹ã‚‰6é€±ä»¥å†…ã€å°‘ãªãã¨ã‚‚1ã¤ä»¥ä¸Šè†µå³¶è‡ªå·±æŠ—ä½“é™½æ€§ã€ãƒ”ãƒ¼ã‚¯ã®C-peptide 0.2 pmol/ml ã§ã‚ã‚‹1åž‹ç³–å°¿ç—…(stage3)ã§ã€æŠ—CD3ãƒ¢ãƒŽã‚¯ãƒãƒ¼ãƒŠãƒ«æŠ—ä½“Teplizumab ã‚ã‚‹ã„ã¯ãƒ—ãƒ©ã‚»ãƒœã‚’12æ—¥é–“ã€26é€±é–“éš”ã§2ã‚¯ãƒ¼ãƒ«ã®æŠ•ä¸Žã‚’ãŠã“ãªã£ãŸã€‚ãƒ—ãƒ©ã‚¤ãƒžãƒªãƒ¼ã‚¨ãƒ³ãƒ‰ãƒã‚¤ãƒ³ãƒˆã¯Î²ç´°èƒžæ©Ÿèƒ½ã®ãƒ™ãƒ¼ã‚¹ãƒ©ã‚¤ãƒ³ã‹ã‚‰ã®å¤‰åŒ–ã§ã€4æ™‚é–“ã®é£Ÿäº‹è² è·ãƒ†ã‚¹ãƒˆ(mixed-meal tolerance test) ã® C-peptide æ¿ƒåº¦æ™‚é–“ã‚«ãƒ¼ãƒ–ã®é¢ç©ã§è©•ä¾¡ã™ã‚‹ã€‚ 78é€±å¾Œã€é£Ÿäº‹è² è·å¾ŒC-peptide é¢ç©å·®ã¯0.13 pmol/ml ( p<0.001)ã€ãƒ”ãƒ¼ã‚¯C-peptide 0.2 pmol/mlä»¥ä¸Šã¯ã€Teplizumab 94.
anpaku 2014/11/30
å‹‰å¼·ã«ãªã‚Šã¾ã™ã€‚ç§ã®ãƒ™ãƒ³ãƒãƒžãƒ¼ã‚¯ã‚µã‚¤ãƒˆã¨ã—ã¦æ´»ç”¨ã‹ãªã€‚

ç³–å°¿ç—…

è«–æ–‡

åŒ»å¸«
ãƒªãƒ³ã‚¯
The New England Journal of Medicineï¼ˆæ—¥æœ¬å›½å†…ç‰ˆï¼‰
NEJMæ—¥æœ¬å›½å†…ç‰ˆã¯ï¼Œå¿…è¦ãªè«–æ–‡ã«ç°¡å˜ã«ã‚¢ã‚¯ã‚»ã‚¹ã§ãã‚‹ã‚ˆã†ã€Œä¸»è¦è«–æ–‡ã‚¢ãƒ–ã‚¹ãƒˆãƒ©ã‚¯ãƒˆã€ã€Œç›®æ¬¡ã€ã€ŒThis Week at NEJM.orgã€ã‚’ï¼Œæ—¥æœ¬èªžè¨³ã«ã¦ã”æä¾›ã—ã¦ã„ã¾ã™ï¼Ž ORIGINAL ARTICLES ç”·æ€§ã«ãŠã‘ã‚‹ãƒ†ã‚¹ãƒˆã‚¹ãƒ†ãƒãƒ³æŠ•ä¸Žã¨éª¨æŠ˜ Testosterone Treatment and Fractures in Menæ€§è…ºæ©Ÿèƒ½ä½Žä¸‹ç—‡ã®ä¸é«˜å¹´ä»¥ä¸Šã®ç”·æ€§ã‚’å¯¾è±¡ã¨ã—ãŸã‚µãƒ–è©¦é¨“ã§ï¼Œãƒ†ã‚¹ãƒˆã‚¹ãƒ†ãƒãƒ³æŠ•ä¸Žã«ã‚ˆã‚Šï¼Œè‡¨åºŠçš„éª¨æŠ˜ã®ç™ºç”ŸçŽ‡ãŒãƒ—ãƒ©ã‚»ãƒœã‚ˆã‚Šã‚‚ä½Žããªã‚‹ã“ã¨ã¯ãªã‹ã£ãŸï¼Žéª¨æŠ˜ã®ç™ºç”ŸçŽ‡ã¯ï¼Œãƒ†ã‚¹ãƒˆã‚¹ãƒ†ãƒãƒ³ç¾¤ã®ã»ã†ãŒæ•°å€¤çš„ã«é«˜ã‹ã£ãŸï¼Ž ã‚ªãƒªã‚¸ãƒŠãƒ«ã‚µã‚¤ãƒˆæ—¥æœ¬èªžã‚¢ãƒ–ã‚¹ãƒˆãƒ©ã‚¯ãƒˆ å¿ƒè‡“å†åŒæœŸãƒ»é™¤ç´°å‹•æ²»ç™‚ã®é•·æœŸè»¢å¸° Long-term Resynchronizationâ€“Defibrillation Therapyå¿ƒè‡“å†åŒæœŸç™‚æ³•æ©Ÿèƒ½ä»˜ãé™¤ç´°å‹•å™¨ã‚’æ¤ãˆè¾¼ã‚“ã æ‚£è€…ã§ã¯ï¼Œé™¤ç´°å‹•å™¨ã‚’æ¤ãˆè¾¼ã‚“ã æ‚£è€…ã¨æ¯”è¼ƒã—ã¦ï¼Œç”Ÿå˜ã¸
anpaku 2014/09/28
Journal

è«–æ–‡

åŒ»å¦é›‘èªŒ

medicine
ãƒªãƒ³ã‚¯
ggsoku.com
anpaku 2014/09/23
ã€Œç”Ÿå‘½ç¶æŒã«ã¨ã£ã¦å¿…é ˆã¨ãªã‚‹é£Ÿå¡©ã‚„æ°´ã§ã•ãˆã€åº¦ã‚’è¶…ãˆãŸæ‘‚å–ã¯æ»ã«ã¤ãªãŒã‚‹ã€‚ä¸€æ—¥ã«40ç¼¶ã®ã‚³ãƒ¼ãƒ©(350mLç¼¶ãªã‚‰14L)ã‚’5æ—¥é–“ã‚‚æ‘‚å–ã—ç¶šã‘ã‚Œã°ã€ç–¾æ‚£ã®ä¸€ã¤ã‚„äºŒã¤ãŒèµ·ã“ã£ã¦ã‚‚ãŠã‹ã—ãã¯ãªã„ã€‚ã€ç¢ºã‹ã«ã«ãã€‚

ç³–å°¿ç—…

ç ”ç©¶

è«–æ–‡
ãƒªãƒ³ã‚¯
ç²¾ç¥žç–¾æ‚£ã¨ç‚Žç—‡ï¼ˆãã®ï¼‘ã€€åŒæ¥µæ€§éšœå®³ã€€part1ï¼‰ : å ´æœ«ï¼°ç§‘ç—…é™¢ã®ç²¾ç¥žç§‘åŒ»ã®blog
5æœˆ27 ç²¾ç¥žç–¾æ‚£ã¨ç‚Žç—‡ï¼ˆãã®ï¼‘ã€€åŒæ¥µæ€§éšœå®³ã€€part1ï¼‰ ã‚«ãƒ†ã‚´ãƒª:åŒæ¥µæ€§éšœå®³ç‚Žç—‡ æœ€è¿‘ã€ç²¾ç¥žç–¾æ‚£ã¨ç‚Žç—‡ã¨ã®é–¢é€£æ€§ã‚’ç¤ºã™è«–æ–‡ãŒæ€¥æ¿€ã«å¢—ãˆã¦ã„ã‚‹ã€‚ã—ã‹ã‚‚ã€ç‚Žç—‡ã¯ã€ä¸æž¢ç¥žçµŒç³»ã«ã®ã¿é™å±€ã—ãŸã‚ˆã†ãªç‚Žç—‡ã§ã¯ãªãã€æ¶ˆåŒ–å™¨ç³»ã®ç‚Žç—‡ã‚„ä»–ã®éƒ¨ä½ã®æ„ŸæŸ“ç—‡ã¨ã„ã£ãŸä¸æž¢ç¥žçµŒç³»ä»¥å¤–ã«ç”±æ¥ã™ã‚‹ç‚Žç—‡ãŒå¼·ãé–¢ä¸Žã—ã¦ã„ã‚‹ã“ã¨ãŒåˆ†ã‹ã£ã¦ãã¦ã„ã‚‹ã€‚ç²¾ç¥žç–¾æ‚£ã®æ ¹æœ¬çš„ãªåŽŸå› ã¯ä¸æž¢ç¥žçµŒç³»ã§ã¯ãªã„å¯èƒ½æ€§ã‚‚ã‚ã‚‹ã®ã§ã‚ã‚‹ã€‚ã“ã®ã‚ˆã†ãªè¦‹åœ°ã‹ã‚‰ã€ä»Šã§ã¯ã€ç²¾ç¥žç–¾æ‚£ã®äºˆé˜²ã‚„äºˆå¾Œç®¡ç†ã«ãŠã„ã¦ã¯ã€èº«ä½“ã®å…¨ã¦ã®éƒ¨ä½ã«ãŠã‘ã‚‹ç‚Žç—‡ã‚’ã©ã®ã‚ˆã†ã«æŠ‘ãˆã¦ã„ãã¹ãã‹ãŒæ¥µã‚ã¦é‡è¦ãªãƒ†ãƒ¼ãƒžã«ãªã‚‹ã¨èªè˜ã•ã‚Œå§‹ã‚ã¦ãã¦ã„ã‚‹ã€‚ã€€ã€€ä»Šå›žã¯ã€ç²¾ç¥žç–¾æ‚£ã®ä¸ã§ã‚‚ã€åŒæ¥µæ€§éšœå®³ï¼ˆBDï¼‰ã«çš„ã‚’çµžã£ã¦ã€åŒæ¥µæ€§éšœå®³ã¨ç‚Žç—‡ã¨ã®é–¢é€£æ€§ã«é–¢ã™ã‚‹æœ€è¿‘ã®è«–æ–‡ã‚„çŸ¥è¦‹ã‚’ç´¹ä»‹ã—ãŸã„ã€‚ å‰æ›¸ãã§è¿°ã¹ãŸã‚ˆã†ã«ã€ã¾ãšã€æ¶ˆåŒ–ç®¡ã®ç‚Žç—‡ãŒåŒæ¥µæ€§éšœå®³ã§ã¯å¤§ããé–¢ä¸Žã—ã¦ã„ã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ã€‚æ˜¨å¹´åº¦ã®12æœˆã«åŒæ¥µæ€§éšœå®³ã¨æ¶ˆåŒ–
anpaku 2014/05/28
ç²¾ç¥žç§‘ç–¾æ‚£ã¨æ„ŸæŸ“ç—‡ã¨ã®é–¢ä¿‚ãŒå¾ã€…ã«ã‚ã‹ã£ã¦ãã¾ã—ãŸãã€‚é¢ç™½ã„ã§ã™ã€‚

åŒ»ç™‚

è«–æ–‡
ãƒªãƒ³ã‚¯
2ã¤ã®ãƒœãƒ¼ãƒ«ã‚’ã¶ã¤ã‘ã‚‹ã¨å††å‘¨çŽ‡ãŒã‚ã‹ã‚‹ - å¤§äººã«ãªã£ã¦ã‹ã‚‰ã®å†å¦ç¿’
ä¸€ã‹æœˆã»ã©å‰ã« New York Times ã§ç´¹ä»‹ã•ã‚Œã¦ã„ãŸè¨˜äº‹ã€‚ The Pi Machine - NYTimes.com ã“ã“ã§ç´¹ä»‹ã•ã‚Œã¦ã„ã‚‹ã®ã¯ã€ãªã‚“ã¨é©šãã¹ãã“ã¨ã«ã€2ã¤ã®ãƒœãƒ¼ãƒ«ã‚’ã¶ã¤ã‘ã‚‹ã ã‘ã§å††å‘¨çŽ‡ï¼ˆ3.1415...ï¼‰ã®å€¤ãŒã‚ã‹ã‚‹ã€ã¨ã„ã†å†…å®¹ã€‚ ã“ã‚Œã ã‘ã ã¨ã€å…¨ç„¶ãƒ”ãƒ³ã¨ã“ãªã„ã¨æ€ã†ã®ã§ã€ã‚‚ã†å°‘ã—è©³ã—ãèª¬æ˜Žã™ã‚‹ã¨ã€æ¬¡ã®ã‚ˆã†ãªã“ã¨ãŒæ›¸ã‹ã‚Œã¦ã„ã‚‹ã€‚ â†“2ã¤ã®ãƒœãƒ¼ãƒ«ã‚’ã€ä¸‹ã®å›³ã‚ˆã†ã«å£ã¨åºŠã®ã‚ã‚‹ç©ºé–“ã«ç½®ãã€‚ â†“ãã®å¾Œã€å£ã‹ã‚‰é ã„æ–¹ã®ãƒœãƒ¼ãƒ«ã‚’ã€ä»–æ–¹ã«å‘ã‹ã£ã¦è»¢ãŒã™ã€‚ å¾Œã¯ã€ãƒœãƒ¼ãƒ«ãŒè¡çªã™ã‚‹å›žæ•°ã‚’ã‚«ã‚¦ãƒ³ãƒˆã™ã‚‹ã ã‘ã§ã€å††å‘¨çŽ‡ãŒã‚ã‹ã‚‹ã‚‰ã—ã„ã€‚ ã“ã‚Œã§ã‚‚ã€ãªã‚“ã ã‹ã‚ˆãã‚ã‹ã‚‰ãªã„ã€‚ ã¾ãš2ã¤ã®ãƒœãƒ¼ãƒ«ãŒåŒã˜è³ªé‡ã§ã‚ã‚‹å ´åˆã‚’è€ƒãˆã¦ã¿ã‚ˆã†ã€‚ ã¾ãšã€æ‰‹å‰ã®ãƒœãƒ¼ãƒ«ãŒä»–æ–¹ã®ãƒœãƒ¼ãƒ«ã«ã¶ã¤ã‹ã‚‹ï¼ˆã“ã‚ŒãŒ1å›žã‚ï¼‰ã€‚ ç¶šã„ã¦ã€ã¶ã¤ã‹ã£ãŸãƒœãƒ¼ãƒ«ãŒç§»å‹•ã—ã¦å£ã«ã¶ã¤ã‹ã‚‹ï¼ˆã“ã‚ŒãŒ2å›žã‚ï¼‰ã€‚ å£ã«ã¶ã¤ã‹ã£ãŸãƒœãƒ¼ãƒ«ãŒè·³ãè¿”ã£ã¦ãã¦
anpaku 2014/04/10
ç‰©ç†å¦çš„ç¾è±¡ã‹ã‚‰å††å‘¨çŽ‡Ï€ã‚’æ¸¬å®šã§ãã‚‹ã¨ã¯ã€å®Ÿã«é¢ç™½ã„ï¼ã“ã‚Œã£ã¦çƒãŒè»¢ãŒã‚‹è·é›¢ã¨é–¢ä¿‚ã—ã¦ã„ã‚‹ã®ã§ã—ã‚‡ã†ã‹ã€‚2ã¤ã®çƒä½“ã®è³ªé‡æ¯”ã«ã‚ˆã£ã¦æ±‚ã‚ã‚‰ã‚Œã‚‹Ï€ã®æ¡æ•°ãŒå¢—ãˆã‚‹ã‚ˆã†ã§ã™ã€‚åŽŸè‘—è«–æ–‡ã‚’èªã‚“ã§ã¿ãŸã„ãã€‚

è«–æ–‡

æ•°å¦

å¦ã³
ãƒªãƒ³ã‚¯
å°‚é–€çš„ãªæ–‡ç« ã‚’èªã‚€ã«ã¯è¨“ç·´ãŒå¿…è¦ã¨ã„ã†å½“ãŸã‚Šå‰ã ãŒã‚ã¾ã‚ŠçŸ¥ã‚‰ã‚Œã¦ã„ãªã„ã“ã¨ï½œColorless Green Ideas
å°‚é–€å®¶ã¯ãŠäº’ã„ã«ã¨ã£ã¦ç†è§£ã—ã‚„ã™ãã™ã‚‹ãŸã‚ã«ã€å°‚é–€ç”¨èªžã‚’ä½¿ã£ã¦æ–‡ç« ã‚’æ›¸ãã€‚ã“ã†ã—ãŸå°‚é–€çš„ãªæ–‡ç« ã‚’ç†è§£ã™ã‚‹ã«ã¯ã—ã£ã‹ã‚Šã¨ã—ãŸè¨“ç·´ãŒå¿…è¦ã§ã‚ã‚‹ã€‚ ã¯ã˜ã‚ã« è¥¿æ—¥æœ¬æ–°èžã®ã‚¦ã‚§ãƒ–ã‚µã‚¤ãƒˆã«æŽ²è¼‰ã•ã‚ŒãŸã‚³ãƒ©ãƒ ã«æ¬¡ã®ã‚ˆã†ãªæ–‡ç« ãŒã‚ã£ãŸã€‚ ãƒãƒƒãƒˆä¸Šã«å…¬é–‹ã•ã‚ŒãŸå¤§å¦ãªã©ã®è«–æ–‡ã«ã‚ã‚‹ã€Œè§£é‡ˆçš„æ–‡è„ˆã€ã€Œãƒ¢ãƒ€ãƒªãƒ†ã‚£è¾žã€ã€Œãƒ‡ã‚£ã‚¢ã‚¹ãƒãƒ©ã€ã€Œèªžç”¨è«–ã€ã£ã¦ä½•ï¼Ÿã€€é«˜åº¦ãªè«–æ–‡ã§ãªã‘ã‚Œã°æ³¨ç›®ã•ã‚Œãšã€ä¸å‹‰å¼·ã¨å†·ç¬‘ã•ã‚Œã‚‚ã™ã‚‹ã ã‚ã†ãŒã€é›£è§£ãªè¨€è‘‰ã§è‡ªå·±é™¶é…”ã™ã‚‹ä¸–ç•Œè¦³ãŒå¦è¡“ç•Œã«åºƒãŒã£ã¦ã„ãªã„ã ã‚ã†ã‹ã€‚ æœ¬æ¥ã€ç ”ç©¶ã¯äººã€ç¤¾ä¼šã«å½¹ç«‹ã¤ã¹ãã‚‚ã®ã¨æ€ã†ãŒã€ãƒãƒƒãƒˆä¸Šã®è«–æ–‡ã«ã¯å€‹äººçš„ãªçŸ¥çš„éŠæˆ¯ã«æµ¸ã£ã¦ã„ã‚‹ç‰©ãŒå°‘ãªã‹ã‚‰ãšæ•£è¦‹ã•ã‚Œã‚‹ã€‚ ç”°ç«¯è‰¯æˆ ï¼ˆ2014å¹´3æœˆ23æ—¥ï¼‰ã€Œï¼³ï¼´ï¼¡ï¼°ç´°èƒžã‚’ã‚ãã‚‹ä¸€é€£ã®å¤§é¨’å‹•ã€ã€Žè¥¿æ—¥æœ¬æ–°èžã€ http://www.nishinippon.co.jp/nnp/desk/article/77391 ã“ã®æŒ‡æ‘˜ã¯å¦¥å½“ãªã‚‚ã®ã§ãªã„ã€‚ç ”ç©¶
anpaku 2014/04/01
ã“ã®æ–°èžç¤¾ã®ã‚³ãƒ©ãƒ ãŒå¯ç¬‘ã—ã„ã§ã™ã‚ˆãã€‚é›£è§£ãªè¨€è‘‰ã‚’ä¸€èˆ¬äººå‘ã‘ã«åˆ†ã‹ã‚Šã‚„ã™ãè§£èª¬ã™ã‚‹ã®ãŒãƒ¡ãƒ‡ã‚£ã‚¢ã®ä»•äº‹ã§ã‚ã‚Šã€å°‚é–€å®¶ã¯åŒã˜å¦è¡“ç ”ç©¶è€…å‘ã‘ã®å½¢å¼çŸ¥ã‚’è«–æ–‡ã«ã‚ˆã‚Šæ§‹ç¯‰ã—ã¦ã„ãã®ãŒä»•äº‹ã§ã™ãã€‚

è«–æ–‡

çŸ¥è˜

ç ”ç©¶
ãƒªãƒ³ã‚¯
STAPç´°èƒžå•é¡Œã‹ã‚‰è¦‹ãˆãŸå¸‚æ°‘ã¨ç§‘å¦è€…ã®ä¹–é›¢ãƒ¼å¾Œç·¨ | Chem-Station (ã‚±ãƒ ã‚¹ãƒ†)
ä¸€èˆ¬çš„ãªè©±é¡Œ STAPç´°èƒžå•é¡Œã‹ã‚‰è¦‹ãˆãŸå¸‚æ°‘ã¨ç§‘å¦è€…ã®ä¹–é›¢ãƒ¼å¾Œç·¨ 2014/3/22 ä¸€èˆ¬çš„ãªè©±é¡Œ, åŒ–å¦è€…ã®ã¤ã¶ã‚„ã, è«–æ–‡ æŠ•ç¨¿è€…: ãƒšãƒªãƒ—ãƒ©ãƒŽãƒ³ å‰å›žã®ãƒã‚¹ãƒˆã§ã‚‚æŒ‡æ‘˜ã—ãŸã‚ˆã†ã«ç§‘å¦ã§æœ€ã‚‚é‡è¦è¦–ã•ã‚Œã‚‹ã®ã¯è«–æ–‡ã§ã™ã€‚ å¦ä¼šç™ºè¡¨ã¯å¦™ãªå†…å®¹ã§ã‚‚å¯èƒ½ã§ã€ç‰©ç†å¦ä¼šã§ã¯çå¦™ãªè‡ªèª¬ã‚’å±•é–‹ã™ã‚‹æ€ªã—ã„äºº(?)ãŸã¡ã®ã‚»ãƒƒã‚·ãƒ§ãƒ³ãŒç”¨æ„ã•ã‚Œã¦ã‚‹ã¨èžã„ãŸã“ã¨ãŒã‚ã‚Šã¾ã™ã€‚ æ›¸ç±ã¯è‡ªç”±ã«ãªã‚“ã§ã‚‚å‰µä½œã™ã‚‹ã“ã¨ãŒã§ãã¾ã™ã—ã€ç‰¹è¨±ã‚‚æ–°è¦æ€§ãŒé‡è¦–ã•ã‚Œã€ç§‘å¦çš„ãªæ£ã—ã•ã®è£ä»˜ã‘ã¯ä¸ååˆ†ãªã“ã¨ãŒã‚ã‚Šã¾ã™ã€‚ ã§ã¯å¦è¡“è«–æ–‡ã¯ãã®ä»–ã¨ä½•ãŒé•ã†ã®ã§ã—ã‚‡ã†ã‹ï¼Ÿãã‚Œã¯ç§‘å¦è€…ãŸã¡ãŒè„ˆã€…ã¨å—ã‘ç¶™ã„ã§ããŸç§‘å¦ã®æ£ã—ã•ã‚’æ‹…ä¿ã™ã‚‹åˆ¶åº¦ä½œã‚Šã«ã‚ã‚Šã¾ã—ãŸã€‚ã“ã“ã§å¦è¡“è«–æ–‡ãŒã©ã®ã‚ˆã†ã«ã—ã¦ä¸–ã«å‡ºã¦ã€ã©ã†ãªã£ã¦ã„ãã®ã‹ã‚’ã‚ã‚‰ãŸã‚ã¦è§£èª¬ã—ãŸã„ã¨æ€ã„ã¾ã™ã€‚è«–æ–‡ã®ä»•çµ„ã¿ã‚’ç†è§£ã—ã¦ã„ãŸã ãã¨STAPç´°èƒžå•é¡Œã®ã©ã“ãŒå•é¡Œãªã®ã‹ãŒã™ã‚“ãªã‚Šã¨ãŠã‚ã‹ã‚Šã„ãŸã ã‘ã‚‹ã¨æ€ã„ã¾ã™ã€‚
anpaku 2014/03/23
ç¢ºã‹ã«ãã†ã ã‚ˆãã€‚æŸ»èªè€…ã‚‚å¿™ã—ã„ã‹ã‚‰ãã€‚

è«–æ–‡

ç§‘å¦

å¦å•

ç§‘å¦ã¨ç¤¾ä¼š
ãƒªãƒ³ã‚¯
JAMA â€“ The Latest Medical Research, Reviews, and Guidelines
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie PolicyÂ |Â Continue
anpaku 2014/02/11
Journal

åŒ»å¦é›‘èªŒ

å¿ƒè‡“ç—…

ç³–å°¿ç—…

è«–æ–‡
ãƒªãƒ³ã‚¯
gacco - ã™ãã«å§‹ã‚ã¦ãšã£ã¨ç¶šã‘ã‚‰ã‚Œã‚‹å‹•ç”»å¦ç¿’ã‚µãƒ¼ãƒ“ã‚¹
ã‚¹ãƒžãƒ›ã‚„ã‚¿ãƒ–ãƒ¬ãƒƒãƒˆã‹ã‚‰ã‚‚å¦ã³ã‚„ã™ãï¼ ãƒ“ã‚¸ãƒã‚¹ã‚¹ã‚ãƒ«ã‹ã‚‰æ•™é¤Šã¾ã§å¹…åºƒã„ã‚¸ãƒ£ãƒ³ãƒ«ã®è¬›åº§ãŒã‚ˆã‚Šèº«è¿‘ã«ã€‚ é€šå‹¤ãƒ»é€šå¦ãªã©ã‚¹ã‚ãƒžæ™‚é–“ã§ã®å¦ç¿’ã«ãœã²ã”åˆ©ç”¨ãã ã•ã„ã€‚ â€»ä¸€éƒ¨ã®å®¹é‡ãŒå¤§ãã„è¬›åº§ã¯ã€ã‚¢ãƒ—ãƒªã§ã®è¡¨ç¤ºã«æ™‚é–“ãŒã‹ã‹ã‚‹å ´åˆãŒã‚ã‚Šã¾ã™ã€‚ â€»æœ‰æ–™è¬›åº§ã¯ã‚¢ãƒ—ãƒªéžå¯¾å¿œã§ã™ã€‚
anpaku 2014/02/04
ã¤ã„ã«æ¥ã¾ã—ãŸãã€‚å¤§å¦è¬›åº§ãŒé–‹æ”¾ã•ã‚Œã¾ã™ã€‚

MOOC

ç„¡æ–™

webã‚µãƒ¼ãƒ“ã‚¹

è«–æ–‡
ãƒªãƒ³ã‚¯
å¿ƒç†å¦è€…ãŒæ•™ãˆã‚‹å°‘ã—ã®åŠªåŠ›ã§å¤§ä½œã‚’æ›¸ãï¼å¤šä½œã«ãªã‚‹ãŸã‚ã®ã‚¦ã‚µã‚®ã«å‹ã¤ã‚«ãƒ¡ã®æ–¹æ³•
Author:ãã‚‹ã¶ã—ï¼ˆèªæ›¸çŒ¿ï¼‰ twitter:@kurubushi_rm ã‚«ãƒ†ã‚´ãƒªåˆ¥è¨˜äº‹ä¸€è¦§ æ–°ã—ã„æœ¬ãŒå‡ºã¾ã—ãŸã€‚ èªæ›¸çŒ¿ã€Žç‹¬å¦å¤§å…¨ã€ãƒ€ã‚¤ãƒ¤ãƒ¢ãƒ³ãƒ‰ç¤¾ 2020/9/29æ›¸ç±ç‰ˆåˆŠè¡Œã€é›»åæ›¸ç±10/21é…ä¿¡ã€‚ ISBN-13 : 978-4478108536 2021/06/02 11åˆ·æ±ºå®š ç´¯è¨ˆ200,000éƒ¨ï¼ˆç´™ï¼‹é›»åï¼‰ 2022/10/26ã€€ï¼‘ï¼”åˆ·æ±ºå®š ç´¯è¨ˆ260,000éƒ¨ï¼ˆç´™ï¼‹é›»åï¼‰ ç´€ä¼Šåœ‹å±‹ã˜ã‚“ã¶ã‚“å¤§è³ž2021ã€€ç¬¬ï¼“ä½ ã‚¢ãƒ³ãƒ€ãƒ¼29.5äººæ–‡æ›¸å¤§è³ž2021 æ–°åˆŠéƒ¨é–€ ç¬¬ï¼‘ä½ ç¬¬ï¼’ã®è‘—ä½œã§ã™ã€‚ 2017/11/20åˆŠè¡Œã€ï¼”åˆ·ã¾ã§æ¥ã¾ã—ãŸã€‚ èªæ›¸çŒ¿ (è‘—) ã€Žå•é¡Œè§£æ±ºå¤§å…¨ã€ ISBN:978-4894517806 2017/12/18 é›»æ›¸å‡ºã¾ã—ãŸã€‚ Kindleç‰ˆãƒ»æ¥½å¤©Koboç‰ˆãƒ»iBooksç‰ˆ éŸ“å›½èªžç‰ˆ ã€Žë¬¸ì œí•´ê²° ëŒ€ì „ã€ã€ç¹ä½“å—ç‰ˆã€Žç·šæ€§VSç’°ç‹€æ€è€ƒã€ã‚‚å‡ºã¦ã„ã¾ã™ã€‚ ã“ã¡ã‚‰ã¯ï¼‘ï¼åˆ·
anpaku 2013/09/14
è«–æ–‡

æ›¸ã

è€ƒãˆæ–¹

å‡ºç‰ˆ
ãƒªãƒ³ã‚¯
ä¿é™ºåŒ»å¦ç·åˆç ”ç©¶æ‰€
anpaku 2013/08/10
åŒ»å¦

ä¿é™º

ä¿é™ºæ³•

è«–æ–‡
ãƒªãƒ³ã‚¯
ä¿é™ºæ³•è§£èª¬ -- ç”Ÿå‘½ä¿é™ºãƒ»å‚·å®³ç–¾ç—…å®šé¡ä¿é™º| æœ‰æ–é–£
å±±ä¸‹ã€€å‹ä¿¡ (æ±äº¬å¤§å¦æ•™æŽˆ)ï¼Œç±³å±±ã€€é«˜ç”Ÿ (ä¸€æ©‹å¤§å¦æ•™æŽˆ)ï¼ç·¨ 2010å¹´05æœˆç™ºå£² ï¼¡ï¼•åˆ¤ä¸Šè£½ã‚«ãƒãƒ¼ä»˜ ï¼Œ 914ãƒšãƒ¼ã‚¸ å®šä¾¡Â 8,360å††ï¼ˆæœ¬ä½“Â 7,600å††ï¼‰ ISBN 978-4-641-13566-6 A Commentary on the Insurance Act of Japan å•†æ³•ä¸€èˆ¬ãƒ»ç·å‰‡ãƒ»å•†è¡Œç‚º > å•†è¡Œç‚º > ä¿é™º 2010å¹´ï¼”æœˆï¼‘æ—¥ã‹ã‚‰æ–½è¡Œã•ã‚Œã‚‹ä¿é™ºæ³•ï¼ˆç”Ÿå‘½ä¿é™ºãƒ»å‚·å®³ç–¾ç—…å®šé¡ä¿é™ºï¼‰ã®é€æ¡è§£èª¬ã€‚å¾“æ¥ã®åˆ¤ä¾‹æ³•ç†ãƒ»ç›£ç£è¦åˆ¶ã‚’è¸ã¾ãˆï¼Œæ–°æ³•ä¸‹ã§ã®ç†è«–ä¸Šãƒ»å®Ÿå‹™ä¸Šã®å•é¡Œç‚¹ã«ã¤ã„ã¦æ¤œè¨Žã—ï¼Œä¿é™ºç†è«–ãƒ»ä¿é™ºæ³•ã®è¦å¾‹ã‚’å®Ÿå‹™ã®å®Ÿæ…‹ã«å³ã—ã¦è©³ã—ãè§£èª¬ã€‚ä»Šå¾Œã®å®Ÿå‹™ã®æŒ‡é‡ã¨ãªã‚‹å¿…æºã®æ›¸ã€‚ åºã€€è«– ä¿é™ºæ³•ã®ç¾ä»£åŒ–ï¼Œä¿é™ºãƒ“ã‚¸ãƒã‚¹ã¨ä¿é™ºç†è«–ã®ç¾ä»£åŒ–ï¼Œç”Ÿå‘½ä¿é™ºæ¥ã®æ´å²ï¼Œä¸»è¦ãªä¿é™ºå•†å“ãƒ»ä¿é™ºã®ä»•çµ„ã¿ï¼Œä¸»ãªå›½ã®ä¿é™º ç¬¬ï¼‘ç« ã€€ç·ã€€å‰‡ ï¼‘æ¡ï¼Œï¼’æ¡ ç¬¬ï¼’ç« ã€€æå®³ä¿é™ºï¼ˆç•¥ï¼‰ ç¬¬ï¼“ç« ã€€ç”Ÿå‘½ä¿é™º ç¬¬ï¼”ç« ã€€å‚·å®³ç–¾ç—…å®š
anpaku 2013/03/25
ä¿é™ºæ³•ã‚’å¦ã¶ä¸Šã§åº§å³ã®ä¸€å†Šã§ã™ãã€‚ç¤¾å†…ã§è¼ªèªä¼šã‚’ã—ãŸæ–¹ãŒè‰¯ã„ã§ã™ã‚ˆã€‚æ„è¦‹æ›¸ã‚’ä½œæˆã™ã‚‹ã¨ãã«å‚è€ƒã«ã—ã¦ã„ã¾ã™ã€‚

èªæ›¸

è«–æ–‡

ä¿é™ºæ³•
ãƒªãƒ³ã‚¯
[2003å¹´æ–‡çŒ®] å°±åŠ´è€…ã§ã¯æœˆæ›œæ—¥ï¼Œå¥³æ€§ã§ã¯åœŸæ›œæ—¥ã«æ€¥æ€§å¿ƒç‹æ¢—å¡žãŒå¤šã„ï½œOACIS
anpaku 2013/03/23
æ€¥æ€§å¿ƒç‹æ¢—å¡ž

è«–æ–‡
ãƒªãƒ³ã‚¯
[2008å¹´æ–‡çŒ®] 1990ï½ž2001å¹´ã«ã‹ã‘ï¼Œç”·å¥³ã¨ã‚‚ã«å¿ƒç‹æ¢—å¡žãŒå¢—åŠ ï½œé«˜å³¶å¾ªç’°å™¨ç–¾æ‚£ç™ºç—‡ç™»éŒ²ç ”ç©¶
anpaku 2013/03/23
è«–æ–‡

æ€¥æ€§å¿ƒç‹æ¢—å¡ž
ãƒªãƒ³ã‚¯
[2005å¹´æ–‡çŒ®] 1988ï½ž1998å¹´ã«ã‹ã‘ï¼Œå¿ƒç‹æ¢—å¡žã®ç™ºç—‡çŽ‡ã¯å¤‰åŒ–ã—ãªã‹ã£ãŸï½œé«˜å³¶å¾ªç’°å™¨ç–¾æ‚£ç™ºç—‡ç™»éŒ²ç ”ç©¶
anpaku 2013/03/23
35ï½ž64æ³ã®ç”·æ€§ã«ãŠã‘ã‚‹å¿ƒç‹æ¢—å¡žã®å¹´é–“ç™ºç—‡çŽ‡ï¼ˆå¹´é½¢èª¿æ•´ï¼Œ10ä¸‡äººã‚ãŸã‚Šï¼‰ã¯55.5ï¼Œå¥³æ€§ã§ã¯9.1ã€‚ ã“ã®çµæžœã¯ï¼ŒWHO MONICAã«ã‚ˆã‚‹å„å›½ã®ãƒ‡ãƒ¼ã‚¿ã¨æ¯”è¼ƒã—ã¦ï¼Œé¡•è‘—ã«ä½Žã‹ã£ãŸã€‚

è™šè¡€æ€§å¿ƒç–¾æ‚£

è«–æ–‡
ãƒªãƒ³ã‚¯
NIPPON DATAã®ãƒˆãƒƒãƒ—ãƒšãƒ¼ã‚¸ï½œå¾ªç’°å™¨ç–«å¦ã‚µã‚¤ãƒˆã€€epi-c.jp
anpaku 2013/03/23
å¿ƒè‡“ç—…

è«–æ–‡
ãƒªãƒ³ã‚¯
1 2 æ¬¡ã®ãƒšãƒ¼ã‚¸